Magazine Article | July 3, 2023

Inside M&A With Bill Symonds

Source: Life Science Leader

By Matthew Pillar, Editor, Bioprocess Online

Bill Symonds, Pharm.D., left Big Pharma in 2014 to jump on the newly built biopharma rollercoaster called Roivant, parent company to, at one time, nearly two dozen startup therapeutic developers. The ride operator was none other than Roivant founder and current U.S. presidential candidate Vivek Ramaswamy. As SVP of clinical research and, later, chief development officer, Symonds had a seat in the front car.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader